IPO value of select CAR-T companies 2013-2015

Selected IPOs of companies with a CAR-T focus between 2013 and 2015 (in million U.S. dollars)*

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

December 2017

Region

United States

Survey time period

as of 2017

Supplementary notes

* CAR-T = chimeric antigen receptor T-cell.
Only includes IPOs where the company had a CAR-T focus at the time of going public. Source: Company press releases.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Cell and gene therapy "

Other statistics that may interest you Cell and gene therapy

Market overview

6

R&D/trials

5

Stem cells

5

Cord blood

5

CAR/CAR-T

4

Miscellaneous

5

Further related statistics

18
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.